149 related articles for article (PubMed ID: 27864930)
1. Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Roekevisch E; Leeflang MMG; Schram ME; Campbell LE; Irwin McLean WH; Kezic S; Bos JD; Spuls PI; Middelkamp-Hup MA
Br J Dermatol; 2017 Dec; 177(6):1745-1746. PubMed ID: 27864930
[No Abstract] [Full Text] [Related]
2. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
3. Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Védie AL; Ezzedine K; Amazan E; Boralevi F; Milpied B; Taïeb A; Seneschal J
Acta Derm Venereol; 2016 Aug; 96(6):802-6. PubMed ID: 26925822
[TBL] [Abstract][Full Text] [Related]
4. Hand eczema, atopic dermatitis and filaggrin mutations in adult Danes: a registry-based study assessing risk of disability pension.
Heede NG; Thuesen BH; Thyssen JP; Linneberg A; Szecsi PB; Stender S; Menné T; Johansen JD
Contact Dermatitis; 2017 Aug; 77(2):95-105. PubMed ID: 28425595
[TBL] [Abstract][Full Text] [Related]
5. The Value of FLG Null Mutations in Predicting Treatment Response in Atopic Dermatitis: An Observational Study in Finnish Patients.
Luukkonen TM; Kiiski V; Ahola M; Mandelin J; Virtanen H; Pöyhönen M; Kivirikko S; Surakka I; Reitamo S; Palotie A; Heliövaara M; Jakkula E; Remitz A
Acta Derm Venereol; 2017 Apr; 97(4):456-463. PubMed ID: 27840886
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapies for severe atopic dermatitis in children and adults.
Flohr C; Irvine AD
J Allergy Clin Immunol; 2013 Sep; 132(3):774-774.e6. PubMed ID: 23993356
[No Abstract] [Full Text] [Related]
7. Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Roekevisch E; Schram ME; Leeflang MMG; Brouwer MWD; Gerbens LAA; Bos JD; Spuls PI
J Allergy Clin Immunol; 2018 Feb; 141(2):825-827.e10. PubMed ID: 29111215
[No Abstract] [Full Text] [Related]
8. Filaggrin loss-of-function mutation R501X and 2282del4 carrier status is associated with fissured skin on the hands: results from a cross-sectional population study.
Thyssen JP; Ross-Hansen K; Johansen JD; Zachariae C; Carlsen BC; Linneberg A; Bisgaard H; Carson CG; Nielsen NH; Meldgaard M; Szecsi PB; Stender S; Menné T
Br J Dermatol; 2012 Jan; 166(1):46-53. PubMed ID: 21777221
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis.
Weidinger S; Beck LA; Bieber T; Kabashima K; Irvine AD
Nat Rev Dis Primers; 2018 Jun; 4(1):1. PubMed ID: 29930242
[TBL] [Abstract][Full Text] [Related]
10. Evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis is currently lacking.
Park YM; Seo SJ
Br J Dermatol; 2020 Sep; 183(3):411. PubMed ID: 32141071
[No Abstract] [Full Text] [Related]
11. Atopic dermatitis, filaggrin mutations and irritant contact dermatitis.
Thyssen JP
Br J Dermatol; 2013 Feb; 168(2):233-4. PubMed ID: 23362965
[No Abstract] [Full Text] [Related]
12. [Eczema herpeticum in a patient with atopic dermatitis, carrying r501x and 2282del4 filaggrin null mutations].
Valdés-Rodríguez R; Saavedra-Alanís VM; Islas-Aguilar MA; Torres-Álvarez B
Gac Med Mex; 2015; 151(2):252-5. PubMed ID: 25946536
[TBL] [Abstract][Full Text] [Related]
13. Review of Critical Issues in the Pathogenesis of Atopic Dermatitis.
Irvine AD; Eichenfield LF; Friedlander SF; Simpson EL
Semin Cutan Med Surg; 2016 Jun; 35(5 Suppl):S89-91. PubMed ID: 27525507
[TBL] [Abstract][Full Text] [Related]
14. Update on systemic therapies for atopic dermatitis.
Denby KS; Beck LA
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
[TBL] [Abstract][Full Text] [Related]
15. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis.
Irvine AD; McLean WH
J Invest Dermatol; 2006 Jun; 126(6):1200-2. PubMed ID: 16702964
[TBL] [Abstract][Full Text] [Related]
16. Filaggrin mutations in early- and late-onset atopic dermatitis.
Szegedi A
Br J Dermatol; 2015 Feb; 172(2):320-1. PubMed ID: 25660681
[No Abstract] [Full Text] [Related]
17. Beyond atopic eczema: filaggrin loss-of-function mutations in dry, fissured hand eczema.
Uter W
Br J Dermatol; 2012 Jan; 166(1):3. PubMed ID: 22212054
[No Abstract] [Full Text] [Related]
18. Filaggrin mutations and the skin.
De D; Handa S
Indian J Dermatol Venereol Leprol; 2012; 78(5):545-51. PubMed ID: 22960809
[TBL] [Abstract][Full Text] [Related]
19. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines.
Hotze M; Baurecht H; Rodríguez E; Chapman-Rothe N; Ollert M; Fölster-Holst R; Adamski J; Illig T; Ring J; Weidinger S
Allergy; 2014 Jan; 69(1):132-5. PubMed ID: 24111531
[TBL] [Abstract][Full Text] [Related]
20. [Azatropin in severe atopic dermatitis: 24 cases].
Malthieu F; Guillet G; Larregue M
Ann Dermatol Venereol; 2005 Feb; 132(2):168-70. PubMed ID: 15798572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
